Breakthrough Genomics

"Since the start of the pandemic, it has been our to provide accurate results in the shortest amount of time. Whether you're getting a -19 or genetic test, we strive to get you the answers you need in order to take the next steps for your health.
"

Want to learn how to efficiently diagnose genetic diseases? Join us on June 17th for an exclusive webinar co-hosted by Novogene Life Sciences and Breakthrough Genomics. The live webinar will be presented by our Founder and CEO, Dr. Laura Li, PhD, FACMGG. Register today by clicking the banner below!

Welcome! You are invited to join a webinar: Diagnose Rare Diseases in Minutes - Clinical Whole Exome Sequencing and the AI/ML-powered ENLITER™ System. After registering, you will receive a confirmation email about joining the webinar. There are 30 million people within the US who carry rare diseases, and often the average time to receive an accurate diagnosis is 4.8 years. With the sequencing cost dropping rapidly, more and more people are doing whole exome sequencing testing for rare disease diagnosis. Whole exome sequencing is....

Great to see Breakthrough Genomics' article on
GenomeWeb! In it, our Founder and CEO, Dr. Laura Li, discusses the development and implementation of a Susceptibility Assessment. We invite you to take a look:

Informatics Startup Breakthorugh Genomics Developing Coronavirus Susceptibility Assessment | Breakthrough Genomics Informatics Startup Breakthorugh Genomics Developing Coronavirus Susceptibility Assessment May 07, 2020 | Neil Versel | GenomeWeb CHICAGO – In responding to the COVID-19 pandemic, genomic interpretation software developer Breakthrough Genomics last month added a research-use-only coronavirus susce...